Author(s)

Fernanda Martinucho Shimith^1,2, Fabiana Barcelos Furtado^2,3, Guilherme Targino Valente^2#*, Rejane Maria Tommasini Grotto^1,2,3#

¹Department of Bioprocess and Biotechnology, School of Agriculture, São Paulo State University (UNESP), Botucatu, Brazil.
²Laboratory of Applied Biotechnology, Clinical Hospital of the Medical School, São Paulo State University (UNESP), Botucatu, Brazil.
³Medical School, São Paulo State University (UNESP), Botucatu, Brazil.

The COVID-19 pandemic has changed the focus of authorities and health organizations with respect to other infectious diseases. This review aims to examine the changes in global epidemiological parameters related to Zika virus during the COVID-19 pandemic and the progress made since 2020 in various aspects of infection. A narrative review was conducted, focusing on articles published between January 2020 and June 2023, covering epidemiology, pathogenicity, transmission, diagnosis, and treatment of Zika virus. The findings of this survey reveal that there has been a significant decrease in reported cases of Zika virus infection during the COVID-19 pandemic, however, advancements have been made in understanding the pathogenicity of the virus and the development of new diagnostic methods, vaccines, and treatments. The lessons learned from the response to COVID-19 have played a pivotal role in guiding efforts that have resulted in progress regarding various aspects related to Zika virus infection.

ZIKV, Epidemiology, Infectious Diseases, Arboviruses

Shimith, F. , Furtado, F. , Valente, G. and Grotto, R. (2023) Zika Virus during the COVID-19 Pandemic: Epidemiological Parameters and Advances in Understanding the Infection. Advances in Infectious Diseases, 13, 527-535. doi: 10.4236/aid.2023.134043.